Compound ID | 936
Synonym(s): OPC 17116
Class: Fluoroquinolone
Spectrum of activity: | Gram-positive & Gram-negative |
Institute where first reported: | Otsuka Pharmaceuticals, Japan; GSK, USA |
Year first mentioned: | 1991 |
Highest developmental phase: | Approved by FDA in 1997 |
Development status: | Discontinued |
Reason Dropped: | Withdrawn from market world-wide due to lengthening QT interval resulting in cardiac abnormalities and death |
Chemical structure(s): | |||||||||||
|
|
External links: | |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/72474 |
Guide to Pharmacology: | grepafloxacin |
Citation: | https://journals.asm.org/doi/10.1128/aac.36.3.573 |